Page last updated: 2024-08-22

cladribine and Leukopenia

cladribine has been researched along with Leukopenia in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (44.44)18.2507
2000's4 (44.44)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dahm, AEA; Dybedal, I; Habberstad, AH; Randen, U; Spetalen, S; Tjønnfjord, GE; Tran, HTT1
Betticher, D; Cerny, T; Fey, MF; Frickhofen, N; Ghielmini, M; Hess, U; Konwalinka, G; Piguet, D; Racine, C; Rufener, B; Schmitz, SF; Tichelli, A; Tobler, A; von Rohr, A; Wernli, M; Zulian, G1
Di Raimondo, F; Ferrajoli, A; Keating, MJ; Lerner, S; Montillo, M; Morra, E; O'Brien, S; Tedeschi, A1
André, M; Costantini, S; Ferrant, A; Francart, J; Lambert, C; Layios, N; Michaux, L; Robert, A; Sonet, A; Van Den Neste, E1
Bashford, J; Bunce, I; Dodds, A; Eliadis, P; Firkin, F; Frost, T; Goldstein, D; Grigg, A; Kelly, C; Kimber, R; Lee, N; Lowenthal, R; Moore, D; Morton, J; Mulligan, S; Parkin, J; Rentoul, A; Rodwell, R; Rooney, K; Stone, J; Taylor, K; Wright, S1
Juliusson, G; Liliemark, J; Porwit, A1
Braylan, RC; Cornfield, DB; Mitchell Nelson, DM; Moller-Patti, D; Rimsza, LM1
Juliusson, G; Liliemark, J1
Beran, M; Estey, EH; Hirsch-Ginsberg, C; Huh, YO; Kantarjian, HM; Keating, MJ; Koller, C; Kurzrock, R; McCredie, KB; O'Brien, SM1

Trials

4 trial(s) available for cladribine and Leukopenia

ArticleYear
Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:10

    Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Disease Progression; Female; Humans; Injections, Subcutaneous; Leukemia, Hairy Cell; Leukopenia; Male; Middle Aged; Recurrence; Survival

2002
Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia.
    Cancer, 2003, Jan-01, Volume: 97, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Leukopenia; Male; Middle Aged; Neoplasm Staging; Neutropenia; Salvage Therapy; Thrombocytopenia; Treatment Outcome

2003
High incidence of complications after 2-chloro-2'-deoxyadenosine combined with cyclophosphamide in patients with advanced lymphoproliferative malignancies.
    Annals of hematology, 2004, Volume: 83, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Female; Humans; Leukopenia; Lymphoproliferative Disorders; Male; Middle Aged; Neoplasms, Second Primary; Opportunistic Infections; Survival Analysis

2004
Intermittent infusion of cladribine (CdA) in previously treated patients with low-grade non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 1997, Volume: 25, Issue:3-4

    Topics: Cladribine; Disease Progression; Dose-Response Relationship, Drug; Humans; Infections; Leukopenia; Lymphoma, Non-Hodgkin; Survival Rate; Thrombocytopenia

1997

Other Studies

5 other study(ies) available for cladribine and Leukopenia

ArticleYear
Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report.
    Journal of medical case reports, 2018, Apr-24, Volume: 12, Issue:1

    Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Bone Marrow; Cladribine; Disease Progression; Fatal Outcome; Humans; Janus Kinase 2; Leukemia, Hairy Cell; Leukemia, Myeloid, Acute; Leukopenia; Male; Neutropenia; Oral Ulcer; Polycythemia Vera; Primary Myelofibrosis; Splenomegaly; Thrombocytopenia

2018
High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma. Australian and New Zealand Lymphoma Study Group.
    British journal of haematology, 1996, Volume: 95, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukopenia; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Opportunistic Infections; Recurrence; Survival Analysis; Thrombocytopenia; Treatment Outcome

1996
The diagnosis of hairy cell leukemia can be established by flow cytometric analysis of peripheral blood, even in patients with low levels of circulating malignant cells.
    American journal of hematology, 2001, Volume: 67, Issue:4

    Topics: Adult; Aged; Antigens, CD; Antineoplastic Agents; Biomarkers; Cladribine; Female; Flow Cytometry; Humans; Immunophenotyping; Leukemia, Hairy Cell; Leukopenia; Male; Middle Aged; Neoplastic Cells, Circulating; Thrombocytopenia; Treatment Outcome

2001
Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections.
    Blood, 1992, Feb-15, Volume: 79, Issue:4

    Topics: 2-Chloroadenosine; Antineoplastic Agents; Candidiasis; Cladribine; Cytomegalovirus Infections; Deoxyadenosines; Humans; Immunophenotyping; Leukemia, Hairy Cell; Leukopenia; Lymphocytes; Monocytes; Neutrophils; Opportunistic Infections; Remission Induction; Thrombocytopenia

1992
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).
    Blood, 1992, Feb-15, Volume: 79, Issue:4

    Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Deoxyadenosines; Drug Resistance; Humans; Leukemia, Hairy Cell; Leukocyte Count; Leukopenia; Male; Middle Aged; Neutrophils; Platelet Count; Remission Induction; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory

1992